<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21808858</PMID><DateCompleted><Year>2012</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1980-5322</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>6</Issue><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>Clinics (Sao Paulo, Brazil)</Title><ISOAbbreviation>Clinics (Sao Paulo)</ISOAbbreviation></Journal><ArticleTitle>Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy's disease).</ArticleTitle><Pagination><StartPage>955</StartPage><EndPage>957</EndPage><MedlinePgn>955-7</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study tremor in patients with X-linked recessive spinobulbar muscular atrophy or Kennedy's disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Ten patients (from 7 families) with a genetic diagnosis of Kennedy's disease were screened for the presence of tremor using a standardized clinical protocol and followed up at a neurology outpatient clinic. All index patients were genotyped and showed an expanded allele in the androgen receptor gene.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean patient age was 37.6 years and mean number of CAG repeats 47 (44-53). Tremor was present in 8 (80%) patients and was predominantly postural hand tremor. Alcohol responsiveness was detected in 7 (88%) patients with tremor, who all responded well to treatment with a &#x3b2;-blocker (propranolol).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Tremor is a common feature in patients with Kennedy's disease and has characteristics similar to those of essential tremor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Francisco A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Neurology Service, Internal Medicine Department, Hospital de Cl&#xed;nicas, University of Paran&#xe1;, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munhoz</LastName><ForeName>Renato P</ForeName><Initials>RP</Initials></Author><Author ValidYN="Y"><LastName>Raskin</LastName><ForeName>Salmo</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Werneck</LastName><ForeName>Lineu C&#xe9;sar</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Teive</LastName><ForeName>H&#xe9;lio A G</ForeName><Initials>HA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clinics (Sao Paulo)</MedlineTA><NlmUniqueID>101244734</NlmUniqueID><ISSNLinking>1807-5932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Y8NXQ24VQ</RegistryNumber><NameOfSubstance UI="D011433">Propranolol</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C537017">Bulbospinal neuronopathy, X-linked recessive</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="N">Muscle Weakness</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014202" MajorTopicYN="N">Tremor</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21808858</ArticleId><ArticleId IdType="pmc">PMC3129962</ArticleId><ArticleId IdType="doi">10.1590/s1807-59322011000600006</ArticleId><ArticleId IdType="pii">S1807-5932(22)00754-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989;112:209&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki K, Katsuno M, Banno H, Takeuchi Y, Atsuta N, Ito M, et al.  CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain. 2008;131:229&#x2013;39. 10.1093/brain/awm289</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm289</ArticleId><ArticleId IdType="pubmed">18056738</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, et al.  Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain. 2006;129:1446&#x2013;55. 10.1093/brain/awl096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl096</ArticleId><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama K, Kihira T, Okawa M, Kajimoto Y, Hiwatani Y, Morita S, et al. [Amyotrophic lateral sclerosis associated with extrapyramidal symptoms or signs] No To Shinkei. 2006;58:779&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17052005</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, et al.  Clinical features of spinal and bulbar muscular atrophy. Brain. 2009;132:3242&#x2013;51. 10.1093/brain/awp258 </Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Shin JH, Park KP, Kim IJ, Kim CM, Lim JG, et al.  Phenotypic variability in Kennedy's disease: implication of the early diagnostic features. Acta Neurol Scand. 2005;112:57&#x2013;63. 10.1111/j.1600-0404.2005.00428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2005.00428.x</ArticleId><ArticleId IdType="pubmed">15932358</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Bulbar and spinal muscular atrophy (Kennedy's disease): a review. Eur J Neurol. 2009;16:556&#x2013;61. 10.1111/j.1468-1331.2009.02591.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02591.x</ArticleId><ArticleId IdType="pubmed">19405197</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G. Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA) Adv Exp Med Biol. 2010;685:64&#x2013;74. 10.1007/978-1-4419-6448-9_6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-6448-9_6</ArticleId><ArticleId IdType="pubmed">20687495</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H, et al.  Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol. 2006;59:520&#x2013;6. 10.1002/ana.20735</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20735</ArticleId><ArticleId IdType="pubmed">16358333</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, et al.  Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomized, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:875&#x2013;84. 10.1016/S1474-4422(10)70182-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70182-4</ArticleId><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>             La Spada AR.             Pagon R A, Bird T D, Dolan C R, Stephens K, edSpinal and bulbar muscular atrophy Gene Reviews [Internet] Seattle (WA): University of Washington, Seattle; 1993-1999 Feb 26 [updated 2006 Dec 28]. ; In:Available at http://www.ncbi.nlm.nih.gov/pubmed/20301508</Citation></Reference><Reference><Citation>Sperfel.d AD, Karitzky J, Brummer D, Schreiber H, H&#xe4;ussler J, Ludolph AC, et al.  X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol. 2002;59:1921&#x2013;6. 10.1001/archneur.59.12.1921</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.59.12.1921</ArticleId><ArticleId IdType="pubmed">12470181</ArticleId></ArticleIdList></Reference><Reference><Citation>Teive HA, Munhoz RP, Werneck LC, Raskin S. Tremor in X-linked recessive spinobulbar muscular atrophy (Kennedy's Disease) Mov Disord. 2008;23:S391:1199. 10.1002/mds.21990</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21990</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic J, Fahn S. Physiologic and pathologic tremors. Diagnosis, mechanism, and management. Ann Intern Med. 1980;93:460&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">7001967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanajima R, Terao Y, Nakatani-Enomoto S, Hamada M, Yugeta A, Matsumoto H, et al.  Postural tremor in X-linked spinal and bulbar muscular atrophy. Mov Disord. 2009;24:2063&#x2013;9. 10.1002/mds.22566</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22566</ArticleId><ArticleId IdType="pubmed">19746452</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>